Community Howard Regional Health
Claim this profile,
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Relapse
Conducts research for Stomach Cancer
233 reported clinical trials
7 medical researchers
Summary
Community Howard Regional Health is a medical facility located in undefined, undefined. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Relapse, Stomach Cancer and other specialties. Community Howard Regional Health is involved with conducting 233 clinical trials across 296 conditions. There are 7 research doctors associated with this hospital, such as Daniel W. Weed, Shih J. Wei, Annette M. Moore, and Radhika Walling.Area of expertise
1Skin Cancer
Global LeaderStage III
Stage IV
Stage II
2Breast Cancer
Global LeaderHER2 positive
ER positive
ER negative
Top PIs
Daniel W. WeedCommunity Cancer Center East6 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
16 drugs studied
Shih J. WeiCommunity Cancer Center East5 years of reported clinical research
Studies Thyroid Cancer
Studies Breast Cancer
3 reported clinical trials
6 drugs studied
Annette M. MooreCommunity Cancer Center South7 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
2 reported clinical trials
6 drugs studied
Radhika WallingCommunity Cancer Center East9 years of reported clinical research
Studies Thyroid Cancer
Studies Breast Cancer
2 reported clinical trials
21 drugs studied
Clinical Trials running at Community Howard Regional Health
Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Oral Cancers
Laryngeal Cancer
Oropharyngeal Carcinoma
ALK Gene Rearrangement
Multiple Myeloma
Squamous Cell Carcinoma
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Community Howard Regional Health?
Community Howard Regional Health is a medical facility located in undefined, undefined. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Relapse, Stomach Cancer and other specialties. Community Howard Regional Health is involved with conducting 233 clinical trials across 296 conditions. There are 7 research doctors associated with this hospital, such as Daniel W. Weed, Shih J. Wei, Annette M. Moore, and Radhika Walling.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.